Related Experiment Video
Updated: Jun 4, 2026

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
Volumetric absorptive microsampling device for forensic Toxicologic screening: A case report as proof-of-concept
Romain Magny1, Jessica Adell2, Laurence Labat1
1Laboratoire de Toxicologie, Fédération de Toxicologie, AH-HP, Hôpital Lariboisière, 2 rue Ambroise Paré, Paris 75010, France; Université Paris-Cité, INSERM, Optimisation thérapeutique en neuropharmacologie INSERM UMRS, 1144, 4 avenue de l'Observatoire, Paris 75006, France.
Volumetric absorptive microsampling (VAMS) provides reliable qualitative toxicological screening in forensic autopsies. This method effectively identifies new psychoactive substances and metabolites, even with limited sample volumes.
Area of Science:
- Forensic toxicology
- Analytical chemistry
- Pharmacology
Background:
- Volumetric absorptive microsampling (VAMS) is an emerging technique for toxicological analysis.
- Its utility in forensic autopsy settings requires further documentation.
- New psychoactive substances (NPS) pose challenges in post-mortem investigations.
Purpose of the Study:
- To evaluate Mitra™ VAMS devices for qualitative toxicological screening in a medico-legal autopsy.
- To assess VAMS applicability for identifying new psychoactive substances (NPS) and their metabolites.
- To compare VAMS performance against conventional sampling methods.
Main Methods:
- Autopsy samples (blood, urine, bile, vitreous humor) collected using conventional and Mitra™ VAMS devices.
- Analysis via liquid chromatography-high-resolution mass spectrometry (LC-HRMS).
- Employing both targeted and untargeted screening approaches, including molecular networking.
Main Results:
- Comparable qualitative detection profiles between conventional and VAMS samples across all matrices.
- Identification of methamphetamine, opioids, and the synthetic cathinone α-PHP using targeted screening.
- Characterization of α-PHP and its metabolites via untargeted analysis and molecular networking, establishing a metabolic profile.
Conclusions:
- Mitra™ VAMS devices are suitable for qualitative toxicological screening and non-targeted analysis in post-mortem investigations, especially when sample volume is limited.
- Integrating VAMS into a structured workflow combining targeted and non-targeted HRMS enhances forensic toxicological analysis.
- VAMS shows potential for improving forensic identification strategies in challenging cases.
More Related Videos
05:31Gas Chromatography-Mass Spectrometry Paired with Total Vaporization Solid-Phase Microextraction as a Forensic Tool
Published on: May 25, 2021
11:14Rapid High-throughput Species Identification of Botanical Material Using Direct Analysis in Real Time High Resolution Mass Spectrometry
Published on: October 2, 2016